Oliver Franklin
Directeur/Membre du Conseil chez JIN MEDICAL INTERNATIONAL LTD.
Postes actifs de Oliver Franklin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JIN MEDICAL INTERNATIONAL LTD. | Directeur/Membre du Conseil | 01/04/2023 | - |
| Independent Dir/Board Member | 01/04/2023 | - | |
| International House of Philadelphia | Corporate Officer/Principal | 25/01/2010 | - |
Dynamis Pharmaceuticals, Inc.
 Dynamis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. It develops drugs diabetic complications and other autoimmune diseases. The company is headquartered in Jenkintown, PA. | Directeur/Membre du Conseil | - | - |
The Philadelphia Foundation
 The Philadelphia Foundation Investment ManagersFinance The Philadelphia Foundation provides asset development and donor services. The company was founded by William Purves Gest on December 20, 1918 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Oliver Franklin
Anciens postes connus de Oliver Franklin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| City of Philadelphia (Pennsylvania) | Corporate Officer/Principal | - | - |
Dynamis Therapeutics, Inc.
 Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Directeur/Membre du Conseil | 25/01/2010 | - |
Statistiques
Internationale
| Etats-Unis | 6 |
| Chine | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Government | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JIN MEDICAL INTERNATIONAL LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Dynamis Therapeutics, Inc.
Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Health Technology |
| International House of Philadelphia | |
| City of Philadelphia (Pennsylvania) | Government |
Dynamis Pharmaceuticals, Inc.
Dynamis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. It develops drugs diabetic complications and other autoimmune diseases. The company is headquartered in Jenkintown, PA. | Health Technology |
The Philadelphia Foundation
The Philadelphia Foundation Investment ManagersFinance The Philadelphia Foundation provides asset development and donor services. The company was founded by William Purves Gest on December 20, 1918 and is headquartered in Philadelphia, PA. | Finance |
- Bourse
- Insiders
- Oliver Franklin
- Expérience
